tender for inj. tocilizumab 162 mg / 0.9 ml in pfs per unit, inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limit ed) per unit (item no. 2582 of ami 2026-27) -quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs pl code : 820115930010

This Government Tender has been Published  by North Central Railway NCR for work related to in Prayagraj, Uttar Pradesh. The Tender work is tender for inj. tocilizumab 162 mg / 0.9 ml in pfs per unit, inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limit ed) per unit (item no. 2582 of ami 2026-27) -quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs pl code : 820115930010. Tender18 Provide this type Government Tender Information on daily basis.

This tender invites eligible contractors, suppliers, manufacturers, consultants, Startups, Msmes, traders and service providers to submit bids for the specified project, supply, service, or work requirement.

Before applying, interested bidders should review the tender scope, eligibility criteria, estimated contract value, important dates, technical requirements, reqired docuent list for bidder and bid submission instructions as per provided in the official tender documents. 

This Verified Information Provide By Tender18 in this page so Bidder Can Easiy  Understanding tender  requirements and bidders can prepare a compliant and competitive tender proposal.

To participate in the tender for inj. tocilizumab 162 mg / 0.9 ml in pfs per unit, inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limit ed) per unit (item no. 2582 of ami 2026-27) -quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs pl code : 820115930010, bidders should first download and review all available tender documents. These documents generally include the Notice Inviting Tender (NIT), Bill of Quantities (BOQ), technical specifications, eligibility criteria, scope of work, and bid submission instructions.

Tender Governemnt Authorities like North Central Railway NCR usually publish these documents on their official eProcurement portals, departmental tender portals, the GeM Tender Portal, or other government procurement platforms or on newspapre. Finding and accessing the correct tender documents across multiple portals can sometimes be time-consuming for bidders. 

To make the process easier, Tender18 provides quick access to the available tender documents related to this Prayagraj , Uttar Pradesh tender on a single page. Businesses involved in related products, services, or works can conveniently download the relevant documents and review the tender requirements without spending time searching across different procurement portals.

The tender for inj. tocilizumab 162 mg / 0.9 ml in pfs per unit, inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limit ed) per unit (item no. 2582 of ami 2026-27) -quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs pl code : 820115930010 from Prayagraj, Uttar Pradesh may be relevant for contractors, suppliers, vendors, manufacturers, consultants, service providers, startups, MSMEs, and other organizations involved in related products, services, or works. However, eligibility to participate depends on the qualification criteria specified by North Central Railway NCR in the official tender documents.

Before submitting a bid, interested applicants should carefully review the eligibility conditions, technical requirements, financial criteria, work experience requirements, annual turnover conditions, registrations, certifications, and any other supporting documents required by the tendering authority. The detailed qualification requirements and bidder eligibility criteria are available in the tender notice and related documents provided on this page. 

Ensuring compliance with all eligibility and qualification requirements before bid submission can help bidders avoid disqualification and improve their chances of successful participation in the tender process.

Tende18 provides comprehensive tender bidding services, including a complete tender summary along with a detailed analysis of the Tender Qualification and Eligibility Criteria.

Interested in participating in the tender for inj. tocilizumab 162 mg / 0.9 ml in pfs per unit, inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limit ed) per unit (item no. 2582 of ami 2026-27) -quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs pl code : 820115930010 issued by North Central Railway NCR for related work in Prayagraj, Uttar Pradesh? TENDER18 provides complete assistance to help businesses understand tender requirements, access tender documents, review eligibility criteria, qualification requirements, important dates, and bid submission guidelines associated with this tender.

Our Tender18 Expert Technical team can assist with vendor and GeM registration on the relevant departmental, eProcurement, GeM, or government tender portal, preparation of technical and financial bid documents, compliance with qualification criteria, document verification, and complete online tender submission support. Whether you are a contractor, supplier, manufacturer, consultant, startup, or MSME working in the field of , Tender18 can help simplify the tender participation process and support you throughout every stage of bidding for this tender. so that tender18 is one the top leading tender consultant in Inda.